Are you Dr. Jaume?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2100 W Central Ave FL 2
Toledo, OH 43606Phone+1 567-420-1600Fax+1 567-420-1633- Is this information wrong?
Summary
- Dr. Juan Jaume, MD is an endocrinologist in Toledo, Ohio. He is currently licensed to practice medicine in Ohio, Wisconsin, and California. He is affiliated with ProMedica Toledo Hospital and The University of Toledo Medical Center.
Education & Training
- University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1988 - 1991
- Zucker School of Medicine at Hofstra/NorthwellInternship, Transitional Year, 1987 - 1988
- University of Buenos AiresClass of 1985
Certifications & Licensure
- CA State Medical License 1991 - 2024
- OH State Medical License 2015 - 2024
- WI State Medical License 2004 - 2017
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity Start of enrollment: 2019 May 29
Publications & Presentations
PubMed
- Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data.Paparodis, R., Bantouna, D., Karvounis, E., Zoupas, I., Livadas, S., Angelopoulos, N., Imam, S., Papadimitriou, D., Jaume, J.> ;Nutrients. 2023 Dec 28
- 1 citationsElevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.Rodis Paparodis, Sarantis Livadas, Evangelos Karvounis, Dimitra Bantouna, Ioannis Zoupas, Nicholaos Angelopoulos, Shahnawaz Imam, Juan Carlos Jaume> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Dec 21
- 2 citationsEfficacy and Safety of Insulin Icodec Versus Glargine U100: A Meta-Analysis of Randomized Controlled Trials.Kirubel Zerihun, Mohammed Mhanna, Hazem Ayesh, Sami Ghazaleh, Yasmin Khader, Azizullah Beran, Abdulaziz Aldhafeeri, Sadikshya Sharma, Amna Iqbal, Hiwot Legesse, Juan J...> ;American Journal of Therapeutics. 2022 Aug 22
- Join now to see all
Press Mentions
- Researchers Develop Pancreatic Beta-Cell Restoring Therapy for Treating Type 1 DiabetesJune 13th, 2022
- A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes — and No One Is Certain WhyMay 29th, 2019
- A New Mouse Model May Unlock the Secrets of Type I DiabetesFebruary 12th, 2019
Grant Support
- An Animal Model For Graves'Disease/OphthalmologyNational Eye Institute2004–2005
- Antigen Specific Immunity In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
- Antigen Specific Immunity In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- An Animal Model For Graves'Disease/OphthalmopathyNational Eye Institute2003
- Ophthalmopathy Of Graves DiseaseNational Eye Institute1997–2001
Professional Memberships
- Member
Hospital Affiliations
- ProMedica Toledo HospitalToledo, Ohio
- The University of Toledo Medical CenterToledo, Ohio